Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Overview
- Life cycle
- Vectors
- Clinical manifestations
- Adverse events
- Infection and intensity
- Determinants of infection
- Diagnosis
- Treatment
- Prevention and control
- Outline
- Historical distributions
- Rapid assessment procedures
- Recent distributions
- Environmental factors
- Ecological zones
- Outline
- Filariasis programmes
- Filariasis co-endemicity
- Onchocerciasis elimination
- Onchocerciasis strategies
- Lymphatic filariasis elimination
- Lymphatic filariasis strategies
- Future focus
- Thank you
Topics Covered
- Biology, disease, infection, diagnosis, treatment and control
- Distributions, mapping procedures and environmental associations
- Implications for filariasis elimination programmes
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Kelly-Hope, L.A. (2020, November 30). Loiasis: African eye worm [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 14, 2024, from https://doi.org/10.69645/QBGY2309.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Louise A. Kelly-Hope has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
HSTalks is pleased to grant unrestricted complimentary access to all lectures in the series Neglected Tropical Diseases. Persons not at a subscribing institution should sign up for a personal account.
Other Talks in the Series: Neglected Tropical Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Louise Kelly-Hope.
I'm a scientist at the Center for Neglected Tropical Diseases in
the Department of Tropical Disease Biology
at the Liverpool School of Tropical Medicine, UK.
Today, I'll be talking to you about loiasis,
also known as African eye worm.
0:18
The talk will include three main sections.
First, I'll provide a brief overview of loiasis and then describe
key factors about the biology, disease, infection, diagnosis,
treatment and control before talking about the distributions, mapping procedures,
environmental associations, and implications for filariasis elimination programmes.
0:41
Loiasis is caused by the filarial nematode Loa loa.
It is transmitted by female tabanid flies of the genus Chrysops.
It is largely confined to the tropical rainforest areas of Central and West Africa.
An estimated 30 million people live in moderate to high risk areas,
predominantly in Cameroon, Democratic Republic of Congo, Gabon, and Nigeria.
It is currently not listed as a Neglected Tropical Disease by
the World Health Organization or included in the Global Burden of Disease Studies.
Its public health importance is related to the risk of serious adverse events or SAEs,
associated with ivermectin-based treatment for onchocerciasis and lymphatic filariasis.
1:25
There are two main stages of the Loa loa life cycle,
the human stage and the fly stage.
Humans are infected during a blood meal of an infected fly,
with third-stage larvae, which is commonly abbreviated to L3.
In the human host, larvae develop into adult
threadlike worms that live and migrate through the subcutaneous tissue,
including the eye area.
While in the human host,
male and female adult worms mate and produce thousands of
microfilariae which are found in the peripheral blood during the day.
This is the time when microfilariae are ingested by a fly during a blood meal.
In the fly, the microfilariae develop into third stage larvae,
which takes between 10 and 12 days,
then they migrate to the fly's proboscis where they
can infect another human when they take a blood meal,
and so this cycle continues.